Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Voyager Therapeutics, Inc. | 65,000 | reported | 01 Feb 2016 | tx 2+65,000 |
| VACCINEX, INC. | 28,586 | reported | 11 May 2021 | tx 3+51,983 |
| Surface Oncology, Inc. | 0 | reported | 08 Sept 2023 | tx 28+1,167,825−772,000 |
| LogicBio Therapeutics, Inc. | 0 | reported | 16 Nov 2022 | tx 4+45,000−12,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Sept 2023 | OTHER | Surface Oncology, Inc. | 129,222 | — | |
| 16 Nov 2022 | OTHER | LogicBio Therapeutics, Inc. | 12,500 | — | deriv |
| 17 Jun 2022 | GRANT_AWARD | LogicBio Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Surface Oncology, Inc. | 24,000 | 0.00 USD | deriv |
| 21 Jul 2021 | SALE | Surface Oncology, Inc. | 127,778 | 6.10 USD | |
| 11 Jun 2021 | GRANT_AWARD | LogicBio Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 11 Jun 2021 | SALE | Surface Oncology, Inc. | 15,273 | 7.61 USD | |
| 10 Jun 2021 | SALE | Surface Oncology, Inc. | 234,727 | 7.66 USD | |
| 11 Jun 2021 | EXERCISE | Surface Oncology, Inc. | 10,273 | 4.14 USD | |
| 10 Jun 2021 | EXERCISE | Surface Oncology, Inc. | 200,000 | 4.14 USD | |
| 10 Jun 2021 | EXERCISE | Surface Oncology, Inc. | 34,727 | 4.14 USD | |
| 11 Jun 2021 | EXERCISE | Surface Oncology, Inc. | 10,273 | 0.00 USD | deriv |
| 10 Jun 2021 | EXERCISE | Surface Oncology, Inc. | 34,727 | 0.00 USD | deriv |
| 10 Jun 2021 | EXERCISE | Surface Oncology, Inc. | 200,000 | 0.00 USD | deriv |
| 11 May 2021 | GRANT_AWARD | VACCINEX, INC. | 28,586 | 0.00 USD | deriv |
| 01 Apr 2021 | GRANT_AWARD | Surface Oncology, Inc. | 4,425 | 0.00 USD | deriv |
| 01 Apr 2021 | GRANT_AWARD | Surface Oncology, Inc. | 35,400 | 0.00 USD | deriv |
| 01 Apr 2021 | GRANT_AWARD | Surface Oncology, Inc. | 15,000 | 0.00 USD | deriv |
| 01 Apr 2021 | GRANT_AWARD | Surface Oncology, Inc. | 15,000 | 0.00 USD | deriv |
| 08 Feb 2021 | EXERCISE | Surface Oncology, Inc. | 2,500 | 3.18 USD | |
| 08 Feb 2021 | SALE | Surface Oncology, Inc. | 2,500 | 12.50 USD | |
| 08 Feb 2021 | EXERCISE | Surface Oncology, Inc. | 2,500 | 0.00 USD | deriv |
| 01 Feb 2021 | EXERCISE | Surface Oncology, Inc. | 2,500 | 3.18 USD | |
| 01 Feb 2021 | SALE | Surface Oncology, Inc. | 2,500 | 10.69 USD | |
| 01 Feb 2021 | EXERCISE | Surface Oncology, Inc. | 2,500 | 0.00 USD | deriv |